tiragolumab,Atezolizumab,bevacizumab,Tocilizumab,TPST-1120,RO7247669,ADG126
Roche,Adagene,JW Pharma,tempest
['atezo', 'morpheus-liver', 'hcc', 'sky,scraper-1', 'tiragolumab', 'bevacizumab', 'roche,(-broche),(-rocheter)']
#roche s anti-tigit #tiragolumab + atezo &amp; bevacizumab showed impressive efficacy with orr 42.5% per recist v1.1 &amp; 55% per hcc modified recist in morpheus-liver study. roche to evaluate the combo in ph3 imbrave152/skyscraper-14 global trial. #asco23 #asco2023 #cancer 
Course5i prides itself in enabling #LifeSciences organizations with insights, #analytics and #AI to drive strategic decisions. Enabling better health outcomes.